Intellectus Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $751K | Buy |
10,881
+2,149
| +25% | +$148K | 0.16% | 158 |
|
|
2025
Q1 | $616K | Sell |
8,732
-3,905
| -31% | -$276K | 0.15% | 166 |
|
|
2024
Q4 | $1.09M | Buy |
12,637
+3,753
| +42% | +$323K | 0.24% | 107 |
|
|
2024
Q3 | $1.06M | Buy |
8,884
+749
| +9% | +$89.2K | 0.27% | 111 |
|
|
2024
Q2 | $1.16M | Sell |
8,135
-200
| -2% | -$28.5K | 0.32% | 86 |
|
|
2024
Q1 | $1.08M | Buy |
8,335
+65
| +0.8% | +$8.41K | 0.28% | 102 |
|
|
2023
Q4 | $856K | Buy |
8,270
+848
| +11% | +$87.7K | 0.25% | 110 |
|
|
2023
Q3 | $675K | Buy |
+7,422
| New | +$675K | 0.21% | 134 |
|
|
2019
Q2 | – | Sell |
-112
| Closed | -$3K | – | 335 |
|
|
2019
Q1 | $3K | Buy |
+112
| New | +$3K | ﹤0.01% | 413 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 426 |
|